Selective inhibition of matrix metalloproteinase-2 and-9 by phosphinic acid pseudo-peptides containing triple-helical structure

Selective inhibition of matrix metalloproteinase-2 and-9 by phosphinic acid pseudo-peptides containing triple-helical structure

Bibliographic Details
Main Authors:	Lauer-Fields, J, Hammer, R, Brew, K, Nagase, H, Fields, G
Format:	Conference item
Published:	2006

Similar Items

Selective hydrolysis of triple-helical peptides by matrix metalloproteinases
by: Lauer-Fields, J, et al.
Published: (2000)

Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases.
by: Lauer-Fields, J, et al.
Published: (2000)

Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9.
by: Lauer-Fields, J, et al.
Published: (2003)

Matrix metalloproteinase triple-helical peptidase activities are differentially regulated by substrate stability.
by: Minond, D, et al.
Published: (2004)

Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates.
by: Lauer-Fields, J, et al.
Published: (2001)

Analysis of matrix metalloproteinase triple-helical peptidase activity with substrates incorporating fluorogenic L- or D-amino acids.
by: Lauer-Fields, J, et al.
Published: (2003)

Kinetic analysis of matrix metalloproteinase triple-helicase activity using fluorogenic substrates
by: Sritharan, T, et al.
Published: (2001)

The roles of substrate thermal stability and P2 and P1' subsite identity on matrix metalloproteinase triple-helical peptidase activity and collagen specificity.
by: Minond, D, et al.
Published: (2006)

Collagenase unwinds triple-helical collagen prior to peptide bond hydrolysis.
by: Chung, L, et al.
Published: (2004)

Development of a solid-phase assay for analysis of matrix metalloproteinase activity.
by: Lauer-Fields, J, et al.
Published: (2004)

Use of Edman degradation sequence analysis and matrix-assisted laser desorption/ionization mass spectrometry in designing substrates for matrix metalloproteinases.
by: Lauer-Fields, J, et al.
Published: (2000)

Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1.
by: Manka, S, et al.
Published: (2012)

Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) - Physiological roles and structural basis of MMP inhibition by TIMP-1
by: Nagase, H, et al.
Published: (2000)

The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
by: Gregg B. Fields
Published: (2019-08-01)

Engineering and expression of ADAMTS-4 and ADAMTS-5, proteolytic enzymes involved in osteoarthritis progression
by: Lauer-Fields, J, et al.
Published: (2005)

Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
by: Wei, S, et al.
Published: (2005)

Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors.
by: Nagase, H, et al.
Published: (2003)

Matrix metalloproteinases in cancer.
by: Itoh, Y, et al.
Published: (2002)

Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
by: Wei, S, et al.
Published: (2003)

Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate.
by: Lauer-Fields, J, et al.
Published: (2008)

Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity.
by: Chung, L, et al.
Published: (2000)

Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase.
by: Itoh, Y, et al.
Published: (1995)

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
by: Visse, R, et al.
Published: (2003)

Progress in matrix metalloproteinase research.
by: Murphy, G, et al.
Published: (2008)

A personal journey with matrix metalloproteinases
by: Nagase, H
Published: (2016)

Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases.
by: Ottl, J, et al.
Published: (2000)

Challenges in Matrix Metalloproteinases Inhibition
by: Helena Laronha, et al.
Published: (2020-05-01)

Activation and Inhibition of Human Matrix Metalloproteinase-9 (MMP9) by HOCl, Myeloperoxidase and Chloramines
by: Yihe Wang, et al.
Published: (2022-08-01)

Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases.
by: Ogata, Y, et al.
Published: (1995)

Engineering of tissue inhibitor of metalloproteinases mutants as potential therapeutics.
by: Nagase, H, et al.
Published: (2002)

Structure and function of matrix metalloproteinases and TIMPs.
by: Nagase, H, et al.
Published: (2006)

Ras, metastasis, and matrix metalloproteinase 9.
by: Bernhard, E, et al.
Published: (2001)

Localizing matrix metalloproteinase activities in the pericellular environment.
by: Murphy, G, et al.
Published: (2011)

Tissue inhibitors of metalloproteinases: evolution, structure and function.
by: Brew, K, et al.
Published: (2000)

Imbalance between matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 expression by tumor cells implicated in liver metastasis from colorectal carcinoma.
by: Ogata, Y, et al.
Published: (2001)

The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.
by: Brew, K, et al.
Published: (2010)

Matrix metalloproteinases and their inhibitors in human vitreous.
by: De La Paz, MA, et al.
Published: (1998)

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis.
by: Murphy, F, et al.
Published: (2002)

The Significance of Matrix Metalloproteinase 9 (MMP-9) and Metalloproteinase 2 (MMP-2) in Urinary Bladder Cancer
by: Jacek Kudelski, et al.
Published: (2023-03-01)

Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface.
by: Itoh, Y, et al.
Published: (1998)